Analysts expect over 2020 rising revenue Amgen

Tomorrow the American Amgen will publish its past quarter figures. Over the current book year the total revenue will be 25,45 billion USD (consensus estimates). This is slightly more than 2019's revenue of 23,36 billion USD.

Historical revenues and results Amgen plus estimates 2020

fundamantele data

Amgen Breda factory


The analysts expect for 2020 a net profit of 9,23 billion USD. The majority of the analysts expects for this year a profit per share of 15,64 USD. Based on this the price/earnings-ratio is 16,49.

Per share the analysts expect a dividend of 6,3 USD per share. Thus the dividend yield equals 2,44 percent. The average dividend yield of the biotech companies equals a limited 0,06 percent.

Newest target prices around 261 USD

Oppenheimer & Co, Independent Research and Citigroup recently provided recommendations for the stock.

Based on the current number of outstanding shares Amgen's market capitalization 162,38 billion USD. The Amgen stock was the past 12 months quite volatile. Since last July the stock is even 51 percent higher. This year the stock price moved between 173 and 265 dollar.

Historical stock prices Amgen period 2007-2020

equity research amgen

Click here for dividend Amgen. On Monday, the stock closed at 257,91 USD. Nieuwsdienst: +31 084-0032-842

Copyright B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.